Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence osteoarthritis
4.2.2 Growing geriatric population
4.2.3 Rising R&D by the key players of the market
4.2.4 Favourable reimbursement policies
4.2.5 Drivers Impact Analysis
4.3 Restraints
4.3.1 High cost of total hip arthroplasty
4.3.2 Incidence of product recalls
4.3.3 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Rising demands for the minimally invasive surgical procedures
4.5 Macroeconomic Indicator
4.6 Product Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS
4.7 Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.1 Bargaining Power of Buyers
5.2.2 Threat of New Entrants
5.2.3 Threat of Substitutes
5.2.4 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
5.5 Demand & Supply: Gap Analysis
6 U.S Direct Anterior Approach (Total Hip Replacement) Market
6.1 Total Hip Replacement
6.1.1 Total Hip Replacement by DAA (Direct anterior approach)
7 Competitive Landscape
7.1 Competitive Landscape
7.1.1 Ambulatory Surgical Centers
7.1.1.1 Introduction
7.1.2 Product Mapping
8 Company Profile
8.1 Johnson & Johnson Services Inc. (DePuy Synthes)
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Products Offering
8.1.4 Key Developments
8.1.5 SWOT Analysis
8.1.6 Key Strategy
8.2 Stryker
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Products Offering
8.2.4 Key Developments
8.2.5 SWOT Analysis
8.2.6 Key Strategy
8.3 Zimmer Biomet
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Products Offering
8.3.4 Key Developments
8.3.5 SWOT Analysis
8.3.6 Key Strategy
8.4 Smith & Nephew
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Products Offering
8.4.4 Key Developments
8.4.5 SWOT Analysis
8.4.6 Key Strategy
8.5 OrthAlign, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Products Offering
8.5.4 Key Developments
8.5.5 SWOT Analysis
8.5.6 Key Strategy
8.6 Proliance Surgeons
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Products Offering
8.6.4 Key Developments
8.6.5 SWOT Analysis
8.6.6 Key Strategy
8.7 The Hip and knee center
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Products Offering
8.7.4 Key Developments
8.7.5 SWOT Analysis
8.7.6 Key Strategy
8.8 Centre for Special Surgery
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Products Offering
8.8.4 Key Developments
8.8.5 SWOT Analysis
8.8.6 Key Strategy
8.9 Bone & Joint Surgery Clinic
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Products Offering
8.9.4 Key Developments
8.9.5 SWOT Analysis
8.9.6 Key Strategy
8.1 Orthoillinois
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Products Offering
8.10.4 Key Developments
8.10.5 SWOT Analysis
8.10.6 Key Strategy
9 Conclusion
9.1 Key Findings
9.1.1 From CEO's View Point
9.2 Key Companies and Surgical Ambulatory Centers to Watch